Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis.

Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1053-60. doi: 10.1007/s00432-011-0979-z. Epub 2011 Apr 17.

2.

The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.

Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.

Cancer. 2006 Sep 15;107(6):1240-7.

3.

Family history of breast cancer, age and benign breast disease.

Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs T, Peiro G, Willett W, Colditz GA.

Int J Cancer. 2002 Jul 20;100(3):375-8.

4.

Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.

Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.

Cancer. 2007 Jan 15;109(2):180-7.

5.

Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.

Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM.

Cancer. 2016 Feb 15;122(4):515-20. doi: 10.1002/cncr.29775. Epub 2015 Nov 13.

6.

Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.

Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5474-9.

7.

Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.

Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR.

Breast J. 2007 Mar-Apr;13(2):115-21.

8.

Lower-category benign breast disease and the risk of invasive breast cancer.

Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N.

J Natl Cancer Inst. 2004 Apr 21;96(8):616-20.

PMID:
15100339
9.

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.

Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC.

Cancer. 2016 Feb 1;122(3):378-85. doi: 10.1002/cncr.29766. Epub 2015 Oct 29.

10.

Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study.

Tamimi RM, Byrne C, Baer HJ, Rosner B, Schnitt SJ, Connolly JL, Colditz GA.

Breast Cancer Res. 2005;7(4):R555-62. Epub 2005 May 16.

11.

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.

Vierkant RA, Degnim AC, Radisky DC, Visscher DW, Heinzen EP, Frank RD, Winham SJ, Frost MH, Scott CG, Jensen MR, Ghosh K, Manduca A, Brandt KR, Whaley DH, Hartmann LC, Vachon CM.

BMC Cancer. 2017 Jan 31;17(1):84. doi: 10.1186/s12885-017-3082-2.

12.

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.

Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW.

Cancer. 2016 Oct;122(19):2971-8. doi: 10.1002/cncr.30153. Epub 2016 Jun 28.

13.

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.

Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR.

Am J Epidemiol. 1988 Sep;128(3):467-77.

PMID:
3414655
14.

A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE.

Cancer Causes Control. 2010 Jun;21(6):821-8. doi: 10.1007/s10552-010-9508-7. Epub 2010 Jan 19.

15.

Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.

Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM.

Breast Cancer Res. 2010;12(4):R61. doi: 10.1186/bcr2624. Epub 2010 Aug 6.

16.

Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.

Houssami N, Abraham LA, Onega T, Collins LC, Sprague BL, Hill DA, Miglioretti DL.

Breast Cancer Res Treat. 2014 Jun;145(3):765-73. doi: 10.1007/s10549-014-2965-z. Epub 2014 May 7.

17.

Invasive breast cancer risk in women with sclerosing adenosis.

Jensen RA, Page DL, Dupont WD, Rogers LW.

Cancer. 1989 Nov 15;64(10):1977-83.

18.

Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA.

Hill DA, Preston-Martin S, Ross RK, Bernstein L.

Cancer Causes Control. 2002 Oct;13(8):711-8.

PMID:
12420949
19.

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.

Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD.

Cancer. 1993 Feb 15;71(4):1258-65. Review.

20.

A prospective study of benign breast disease and the risk of breast cancer.

London SJ, Connolly JL, Schnitt SJ, Colditz GA.

JAMA. 1992 Feb 19;267(7):941-4. Erratum in: JAMA 1992 Apr 1;267(13):1780.

PMID:
1734106

Supplemental Content

Support Center